Ghost Tree Capital, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $658,453 - $841,734	-48,487 Reduced 21.55%	176,513 $2.78 Million
Q4 2023 Feb 14, 2024	SELL	$10.11 - $16.54 $1.01 Million - $1.65 Million	-100,000 Reduced 30.77%	225,000 $3.63 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $4.05 Million - $5.03 Million	325,000 New	325,000 $4.13 Million
Q4 2017 Feb 14, 2018	SELL	$16.54 - $24.2 $1.07 Million - $1.56 Million	-64,410 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $1.14 Million - $1.22 Million	64,410	64,410 $1.22 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.